• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

MedAlliance picks up FDA IDE nod for drug-eluting balloon

January 10, 2023 By Sean Whooley

MedAlliance SELUTION SLR

MedAlliance announced today that its novel sirolimus-eluting balloon received conditional FDA investigational device exemption (IDE). Geneva, Switzerland-based MedAlliance can now initiate its pivotal clinical trial for the treatment of coronary de novo lesions. MedAlliance received its first IDE for Selution SLR in below-the-knee indications in May 2022. It picked up a second IDE in August. […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Vascular Tagged With: FDA, MedAlliance

FDA approves next-gen inhaled nitric oxide delivery system from Vero Biotech

January 10, 2023 By Sean Whooley

Vero Biotech Genosyl iNO delivery system

Vero Biotech announced that it received FDA approval for its latest-generation tankless inhaled nitric oxide (iNO) delivery system. Atlanta-based Vero Biotech developed its third-generation Genosyl delivery system for respiratory therapists. Its new features include faster dosing, simpler workflow and operational efficiency. The system speeds up dosing with an adaptive sensor and automated cassette activation feature. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Food & Drug Administration (FDA), Hospital Care, Pediatrics, Pharmaceuticals, Regulatory/Compliance, Technology Tagged With: FDA, Vero Biotech

EOFlow submits wearable, disposable insulin patch pump for FDA 510(k) clearance

January 9, 2023 By Sean Whooley

EOFlow EOPatch insulin patch

EOFlow announced recently that it submitted a 510(k) application to the FDA for its EOPatch wearable, disposable insulin pump. San Jose, California-based EOFlow submitted its application on Dec. 27, 2022. It aims to enter the U.S. diabetes market, expanding its reach outside Korea. The company said in a news release that over 600 people in […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Technology Tagged With: eoflow, FDA

Beta Bionics appoints new CMO as it prepares for artificial pancreas launch

January 9, 2023 By Sean Whooley

Dr. Steven Russell Beta Bionics

Beta Bionics announced that it appointed Dr. Steven Russell as its chief medical officer (CMO) as it readies itself for a major product launch. Concord, Massachusetts-based Beta Bionics develops the iLet bionic pancreas system. The pocket-sized, wearable, investigational iLet device autonomously doses insulin. Worn like an insulin pump, iLet users only enter body weight to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel Tagged With: Beta Bionics, personn

Dexcom appoints former J&J exec as CCO, sets 2023 guidance

January 9, 2023 By Sean Whooley

Teri Lawver Dexcom CCO

Dexcom (Nasdaq:DXCM) announced today that it appointed Teri Lawver to its newly created role of chief commercial officer (CCO). Lawver’s position oversees the global commercial organization at the continuous glucose monitoring (CGM) technology developer. She holds responsibility for global sales, marketing and customer experience. Before joining San Diego–based Dexcom, Lawver spent two decades in a […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Personnel, Wall Street Beat Tagged With: Dexcom, Personnel Moves

Sustained Therapeutics advances novel drug delivery platform

January 6, 2023 By Sean Whooley

Sustained Therapeutics drug delivery platform

Sustained Therapeutics announced that it received regulatory approval in Canada to begin a Phase II trial of its novel pain medication. Vancouver, BC-based Sustained Therapeutics develops a long-lasting non-opioid pain medication. Its trial evaluates a sustained-release platform technology to aid in chronic pain treatment. The company said in a news release that it designed the […]

Filed Under: Business/Financial News, Clinical Trials, Drug-Device Combinations, Featured, Pain Management, Pharmaceuticals, Regulatory/Compliance Tagged With: Sustained Therapeutics

Know Labs wins new glucose monitoring patent

January 4, 2023 By Sean Whooley

Know Labs KnowU Uband non-invasive glucose monitor

Know Labs (NYSE:KNW) announced today that it received a new patent equating its diagnostic technology to the current glucose monitoring standard. Seattle-based Know Labs develops the Bio-RFID technology. It uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. It integrate into wearable, mobile or bench-top form factors. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Know Labs

OraMed wins U.S. combination therapy patent for oral GLP-1, insulin

January 4, 2023 By Sean Whooley

Oramed Logo

Oramed Pharmaceuticals (Nasdaq:ORMP) announced today that it received a new patent for its oral diabetes treatment. The U.S. Patent and Trademark Office (USPTO) granted a patent titled “Methods and Compositions for Treating Diabetes.” This patent extends a patent previously granted in May 2022. According to a news release, the patent addresses methods and compositions for […]

Filed Under: Business/Financial News, Diabetes, Pharmaceuticals Tagged With: oramedpharmaceuticals

Ypsomed, Mediq complete sale of DiaExpert

January 3, 2023 By Sean Whooley

Ypsomed Logo 770x500

Ypsomed and Mediq announced today that they completed the sale of mail-order retailer for diabetes care DiaExpert. Germany-based DiaExpert specializes in insulin pump therapy. The companies previously announced the sale of DiaExpert in October. This sale allows Ypsomed to focus on the manufacture and sale of its own medical technologies. That focus continues to narrow […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Mergers & Acquisitions, Technology Tagged With: Ypsomed

The 10 biggest diabetes tech stories from 2022

December 27, 2022 By Sean Whooley

Diabetes stories 2022 insulet dexcom abbott senseonics

2022 represented a landmark year for next-generation diabetes tech. Here are the biggest stories from the past year. Some companies picked up major regulatory nods. Others experienced major regulatory setbacks. Partnerships were formed and ended, while mergers and acquisitions came and went. There were many stories to choose from in the world of diabetes tech, […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Recalls, Regulatory/Compliance, Technology, Wall Street Beat Tagged With: abbott, BD, CamDiab, Dexcom, embecta, Insulet, Medtronic, Senseonics, Sernova Inc, Tandem Diabetes Care, Ypsomed

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 75
  • Page 76
  • Page 77
  • Page 78
  • Page 79
  • Interim pages omitted …
  • Page 170
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS